The CrickConnect team are delighted to be able to invite community members to join us for the institute's regular Crick Lecture.

Crick Lectures provide a broad insight into biomedical research from leading scientists. Not to be missed, the one-hour lectures are the event of the week for the Crick community to come together. 

This installment will be delivered by Professor Kristian Helin, Chief Executive and President of the Institute of Cancer Researc

Crick Lectures take place weekly (usually on Thursday at 16:00). They are given by leading scientists and aim to be accessible to scientists across different disciplines, while also offering something for the specialist.

Due to the pioneering and sensitive nature of some of the research discussed in these lectures, only Crick Lectures from selected speakers will be shared, and we ask all attendees to respect the private nature of these talks by refraining from making any type of recording, sharing access details or in any other way compromising the research that is discussed.

Speaker Profile

Professor Kristian Helin’s Epigenetics and Cancer team studies the role of chromatin-associated proteins (epigenetics) in the regulation of transcription, cell fate decisions and in cancer. The team is also using functional genetic screens to identify potential novel targets for the development of anti-cancer therapy.

The Helin lab studies the role of epigenetic factors in transcription, cell fate decisions and in cancer. In recent years, the group has developed a particular interest in acute myeloid leukemia, in part because there is an unmet need for the development of novel therapies and in part because many epigenetic regulators are altered in AML. The work on AML has led to the identification of potential novel targets for the treatment of AML and insights into how normal haematopoiesis is regulated.